Net Income Loss

Name: Iovance Biotherapeutics, Inc. Net Income Loss by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Iovance Biotherapeutics, Inc.·Business Segments·1 segment·Rolls up to Net Income

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Business Segments	-$116.16M	-$111.66M	-$91.25M	-$71.9M	-$79.05M
Total	-$116.16M	-$111.66M	-$91.25M	-$71.9M	-$79.05M

Business SegmentsView metric